Form 8-K - Current report:
SEC Accession No. 0001193125-23-063732
Filing Date
2023-03-08
Accepted
2023-03-08 07:02:30
Documents
16
Period of Report
2023-03-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d463506d8k.htm   iXBRL 8-K 39560
2 EX-4.1 d463506dex41.htm EX-4.1 875950
3 EX-4.2 d463506dex42.htm EX-4.2 49214
4 EX-4.3 d463506dex43.htm EX-4.3 54867
5 EX-10.1 d463506dex101.htm EX-10.1 93212
  Complete submission text file 0001193125-23-063732.txt   1496930

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nvta-20230307.xsd EX-101.SCH 2849
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvta-20230307_lab.xml EX-101.LAB 17234
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvta-20230307_pre.xml EX-101.PRE 10811
10 EXTRACTED XBRL INSTANCE DOCUMENT d463506d8k_htm.xml XML 3267
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 23714844
SIC: 8071 Services-Medical Laboratories